Creutzfeldt-Jakob disease (CJD) is a neurodegenerative disorder belonging to the group of transmissible spongiform encephalopathies. The transition of physiological, soluble, neuroprotective prion protein PrPc into its insoluble, misfolded isoform PrPSc remains its central pathogenic event. The progressive accumulation of isoform PrPSc within the brain tissue results in spongiform degeneration and a plethora of clinical symptoms. Typically, CJD manifests as progressive dementia with myoclonus, visual or cerebellar dysfunction, pyramidal/ extrapyramidal signs or akinetic mutism. However, a growing number of studies indicate that CJD may present with prodromal psychiatric manifestations including anhedonia, anxiety, irritability, depression, insomnia, psychosis and catatonic behavior. We present a case of CJD with a history of prodromal psychiatric symptoms and catatonic behavior diagnosed by brain biopsy.
INTRODUCTION
Creutzfeldt-Jakob disease (CJD) is a neurodegenerative disorder belonging to the group of transmissible spongiform encephalopathies. The transition of physiological, soluble, neuroprotective prion protein PrPc into its insoluble, misfolded isoform PrPSc remains the central pathogenic event in this disorder [1] . PrPSc creates toxic deposits resilient to cellular clearance mechanisms [2] . Their progressive accumulation within the brain tissue results in spongiform degeneration and a plethora of clinical symptoms. Typically, CJD manifests as progressive dementia with myoclonus, visual or cerebellar dysfunction, pyramidal/extrapyramidal signs or akinetic mutism. However, a growing number of studies indicate that CJD may present with prodromal psychiatric manifestations including anhedonia, anxiety, irritability, depression, insomnia, psychosis and behavioral changes [3] . Brown et al. [4] showed that behavioral changes occurred in 30% of patients at the disease onset and in 57% at the later stages. In another study, 5 out of 8 CJD patients showed psychiatric manifestation including mood, thought and behavior disruption; 4 out of 8 of these patients were diag-nosed with different psychiatric disorders [5] . Mood disorder symptoms, paranoid ideation and hallucinations were present in 7 out of 11 CJD cases described in the study by Satishchandra et al. [6] . A retrospective study indicated that 18-39% of patients with sporadic CJD presented with psychiatric symptoms such as depressive disorder, emotional lability or personality changes [7] . CJD cases from Brazil presented by Sobreira et al. [8] showed heterogeneous psychiatric manifestations including sudden psychomotor agitation, aggression, disinhibition and cognitive dysfunctions. Moreover, it was reported that early stages of the disease may manifest as dissociative disorder with histrionic behavior and dissimulation [9] . Siwek et al. [10] presented a case of a 34-year-old female with CJD, primarily diagnosed with conversion disorder, who manifested with blurred vision, diplopia and gait impairment. All of these reported cases indicate that CJD may manifest with a plethora of uncharacteristic, atypical psychiatric symptoms and it is likely that psychiatrists may be the first-line doctors dealing with a CJD patient at the early stages of the disease [11] .
Catatonia is a neuropsychiatric syndrome characterized by mutism, stupor, negativism and hypo/hyperkinesis. While it is mostly associated with schizophrenia, catatonia is often caused by affective disorders and neurological illnesses [12] . We present a case of CJD diagnosed by brain biopsy in a patient with a history of prodromal psychiatric symptoms and catatonic behavior.
CASE
A 49-year-old woman was admitted to a psychiatric hospital for the first time 9 months before the proper diagnosis was established, due to her bizarre behavior, deterioration of social interactions, reduced food intake, hallucinations, psychomotor retardation with periodic episodes of agitation, passive negativism and sleep disorders. All symptoms, lasting for a period of 4 weeks, indicated an acute psychotic disorder and the patient was discharged on olanzapine 5mg daily and biperiden 2mg daily. After the discharge, the patient's family observed a deterioration in her health; she ceased to be independent and required assistance with basic activities. There was also a significant deterioration in her vision. Due to lowered mood and psychomotor retardation, the patient was admitted to the psychiatric hospital for the second time. Her symptoms remained stable except for increasing muscle rigidity. An electroencephalogram (EEG) test showed pathological tracing with diffused and generalized paroxysmal theta activity. She was discharged with the diagnosis of drug-induced Parkinsonism and treated with biperiden 2mg three times a day without concomitant antipsychotic medication. A month later, the patient was again admitted to the psychiatric hospital because of aggressive and agitated behavior. A hostile attitude towards the hospital staff was also marked. The patient's condition gradually deteriorated further, with mutism, increased hypertonia and negativism. The clinical picture tended towards a suspicion of the catatonic syndrome. Olanzapine 10mg daily was administered. However, after several days the patient's body temperature went up to 39ºC and olanzapine was discontinued. As infection was suspected, she was started on intravenous ceftriaxone. However, subsequent internal medicine consultation with blood and urine culture and cerebrospinal fluid (CSF) examination as well as head computed tomography (CT) excluded the suspected source of infection (including neuroinfection), leading to a suspicion of neuroleptic malignant syndrome.
Finally, due to unclear clinical presentation, the patient was admitted to the Clinical Department of Adult Psychiatry at the University Hospital in Kraków in a state of consciousness requiring differentiation between stupor and vegetative state. The physical examination revealed eyes opening spontaneously and no verbal contact, but the patient responded with a grimace to painful stimulation. No spontaneous movements, hypertonia and muscle atrophy of the upper and lower limbs were present. Because of dysphagia, the patient was supported with a feeding tube.
A consecutive neurological examination identified spastic quadriplegia and jaw muscles spasm. The palmomental reflex was present on the left side. The clinical picture of progressive encephalopathy of unknown etiology suggested further diagnostic evaluation towards CJD. Head magnetic resonance imaging (MRI) revealed diffuse linear cortical enhancement at diffusion-weighted imaging sequence. The neuroimaging result prompted the team to consider a CJD diagnosis despite lack of typical changes in the basal ganglia.
The patient, conscious with no verbal contact, was then admitted to the Neurology Department at the University Hospital in Kraków. Neurological examination showed spastic quadriplegia (more severe on the right side) with hyperreflexia and four limbs' contractures. The EEG showed generalized slow activity without rhythmic slow waves typical for CJD and CSF analysis did not reveal 14-3-3 protein elevation. Because of the lack of typical CJD findings from the EEG and CSF examination and a concomitant clinical and MRI picture suggesting diffuse encephalopathy, brain biopsy was performed after obtaining the approval from a family court.
Applying the method of open brain biopsy, the sample of approximately 1.5cm in diameter containing both the cortex and subcortical white matter was obtained from the left temporal lobe. The tissue was treated accordingly to the universally accepted methods for handling tissue suspected of being "infected" with a pathogenic prion strain, including 1h immersion in formic acid. Histopathological investigations including immunohistochemistry were made on sections of samples embedded in paraffin blocks. Hematoxylin and eosin (H&E) staining showed vacuolization in the neuropil and neuronal loss indicating spongiform degeneration (Fig. 1) . Immunohistochemical staining for PrP demonstrated immunopositive deposits around spongiform changes resistant to autoclaving and proteinase K digestion (Fig. 2) . These results confirmed the diagnosis of CJD in our patient. 
DISCUSSION
Reports indicate that CJD, as well as other prion diseases like fatal familial insomnia, may manifest as catatonia [13] . Table 1 Electroconvulsive therapy (ECT), which remains the predominant method of treatment in catatonia, may not only be ineffective in CJD, but in some cases may also be associated with symptoms' progression. Grande et al. [15] reported a case of CJD patient who, after eight bilateral ECT sessions in 25 days, became disoriented, inattentive and perseverative, with hypophonic, monotonous speech with a paucity of content and difficulties in naming and understanding complex orders. The patient also developed rigidity, postural tremor, bradykinesia, gait disturbances and became wheelchair bound [15] . In such cases of ECT-resistant catatonic behavior, EEG, MRI and CSF examinations should be conducted. The EEG pattern differs depending on the stage of the disease. In the early stages, diffuse slowing and frontal rhythmic delta activity (FIRDA) may be present, whereas the middle and late stages of sporadic CJD (sCJD) present with disease-typical periodic sharp wave complexes (PSWC) [16] . Control EEG performed in the presented case revealed a pattern characteristic for sCJD. Thus, there was no need for further diagnostics for variant CJD (vCJD) (e.g. tonsil biopsy).
In CSF tests, elevated 14-3-3 protein is detected in about 90% cases of sCJD, but in only 50% cases of vCJD [17] . However, histological examination is the only method of final diagnosis. Brain biopsy sampling may be helpful in the diagnostic approach to rare cases of atypical manifestation of this disease, when CSF parameters, EEG and MRI results are inconsistent and neuropsychological examination is not possible [18] .
The presented case indicates that sCJD should be considered in the wide differential diagnosis of catatonic behavior, especially when there is a short duration of psychiatric symptoms and their resistance to treatment, as well as rapid deterioration of patient's health.
